A newly developed astatine-211 (211At)-labeled peptide drug inhibits malignant melanoma cells by releasing alpha particles in the targeted cancer tissue.

Incidence rates of melanoma are declining among older adolescents and young adults, but mortality rates are on the rise.

Cancer-associated fibroblasts (CAFs) play an important role in metastatic melanoma, and an enhanced understanding of that role could lead to important new therapeutic pathways, according to a new ...